US Stock MarketDetailed Quotes
MTNB Matinas BioPharma
- 0.6430
- +0.0143+2.27%
Close Nov 29 13:00 ET
- 0.6430
- 0.00000.00%
Post 17:01 ET
3.27MMarket Cap-135P/E (TTM)
0.6600High0.6065Low10.61KVolume0.6600Open0.6287Pre Close6.67KTurnover0.21%Turnover RatioLossP/E (Static)5.09MShares21.500052wk High0.21P/B3.19MFloat Cap0.500052wk Low--Dividend TTM4.96MShs Float197.5000Historical High--Div YieldTTM8.51%Amplitude0.5000Historical Low0.6280Avg Price1Lot Size
Matinas BioPharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | -65.62%1.1M | 0 | 0 | 0 | 1.1M | 9,560.61%3.19M | 319,319.22%1.06M |
| Operating revenue | --0 | --0 | --0 | -65.62%1.1M | --0 | --0 | --0 | --1.1M | 9,560.61%3.19M | 319,319.22%1.06M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -28.58%4.38M | -5.20%5.84M | -11.67%5.9M | -10.50%24.86M | -10.03%5.89M | -5.99%6.13M | -11.86%6.16M | -13.47%6.68M | 12.15%27.78M | -2.55%6.54M |
| Selling and administrative expenses | -24.55%2.14M | -5.08%2.47M | -9.44%2.46M | -6.55%10.37M | -16.97%2.22M | 0.75%2.84M | -9.12%2.6M | -1.17%2.71M | 8.98%11.1M | 8.15%2.68M |
| -General and administrative expense | -24.55%2.14M | -5.08%2.47M | -9.44%2.46M | -6.55%10.37M | -16.97%2.22M | 0.75%2.84M | -9.12%2.6M | -1.17%2.71M | 8.98%11.1M | 8.15%2.68M |
| Research and development costs | -32.05%2.24M | -5.28%3.37M | -13.20%3.45M | -13.13%14.49M | -5.22%3.67M | -11.11%3.3M | -13.76%3.56M | -20.25%3.97M | 14.37%16.68M | -8.79%3.87M |
| Operating profit | 28.58%-4.38M | 5.20%-5.84M | -5.66%-5.9M | 3.35%-23.77M | -7.43%-5.89M | -12.30%-6.13M | -3.95%-6.16M | 27.66%-5.59M | 0.59%-24.59M | 18.38%-5.48M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | 34.18%106K | 21.21%120K | 6.85%78K | -77.07%824K | -68.96%573K | 79K | 4,850.00%99K | -95.81%73K | 147.45%3.59M | 12,019.22%1.85M |
| Special income (charges) | ---- | ---- | ---- | -86.14%484K | ---- | ---- | ---- | ---- | 162.88%3.49M | 373,929.79%1.76M |
| -Gain on sale of business | ---- | ---- | ---- | -86.14%484K | ---- | ---- | ---- | ---- | 162.88%3.49M | 373,929.79%1.76M |
| Other non- operating income (expenses) | 34.18%106K | 21.21%120K | 6.85%78K | 233.33%340K | 0.00%89K | --79K | 4,850.00%99K | 630.00%73K | -17.74%102K | 466.81%89K |
| Income before tax | 29.40%-4.28M | 5.63%-5.72M | -5.64%-5.82M | -9.26%-22.94M | -46.23%-5.31M | -10.86%-6.06M | -2.31%-6.06M | 7.78%-5.51M | 9.82%-21M | 45.75%-3.63M |
| Income tax | ||||||||||
| Net income | 29.40%-4.28M | 5.63%-5.72M | -5.64%-5.82M | -9.26%-22.94M | -46.23%-5.31M | -10.86%-6.06M | -2.31%-6.06M | 7.78%-5.51M | 9.82%-21M | 45.75%-3.63M |
| Net income continuous Operations | 29.40%-4.28M | 5.63%-5.72M | -5.64%-5.82M | -9.26%-22.94M | -46.23%-5.31M | -10.86%-6.06M | -2.31%-6.06M | 7.78%-5.51M | 9.82%-21M | 45.75%-3.63M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 29.40%-4.28M | 5.63%-5.72M | -5.64%-5.82M | -9.26%-22.94M | -46.23%-5.31M | -10.86%-6.06M | -2.31%-6.06M | 7.78%-5.51M | 9.82%-21M | 45.75%-3.63M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 29.40%-4.28M | 5.63%-5.72M | -5.64%-5.82M | -9.26%-22.94M | -46.23%-5.31M | -10.86%-6.06M | -2.31%-6.06M | 7.78%-5.51M | 11.33%-21M | 45.75%-3.63M |
| Basic earnings per share | 38.85%-0.85 | 33.33%-1 | 0.00%-1.5 | -10.00%-5.5 | -44.00%-1.44 | 7.33%-1.39 | 0.00%-1.5 | 0.00%-1.5 | 9.09%-5 | 33.33%-1 |
| Diluted earnings per share | 38.85%-0.85 | 33.33%-1 | 0.00%-1.5 | -10.00%-5.5 | -44.00%-1.44 | 7.33%-1.39 | 0.00%-1.5 | 0.00%-1.5 | 9.09%-5 | 33.33%-1 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data